Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adamis, Assembly, Can-Fite, Connect, Inmune, Pfizer, Quantum, Quest, Takeda.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astellas, Autolus, Bavarian Nordic, Code, Exevir, Immutep, Lumen, Merck, Pfizer, Revance, Ridgeback, Rigel, Tevogen, Xeris.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AC Immune, Adial, Amarin, Axerovision, Bayer, Curevac, Genentech, Gennova, Gensight, GSK, HDT, J&J, Nocion, Pharmaxis, Poseida, Roche, Senhwa, SK Bioscience, Tauriga.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bayer, Bone, Daiichi, Janssen, Kinnov, Lysogene, Nrx, Pfizer, Regeneron, Sanofi, Uniqure.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agenus, Aileron, Airway, Alzecure, Amgen, Ose, Quantum.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amneal, Astrazeneca, Edesa, Everest, Hutchmed, Inmune, Ose, Pardes, Ryvu, Servier, Turn.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Affibody, Arcutis, Ascletis, Bluewillow, Bridgebio, Brii, Clarity, Cortexyme, Cytodyn, Emergent, Fibrogen, Flexion, FSD, IBT, Inmagene, Janssen, Lianbio, Lipocine, Merck, Novavax, Noxopharm, Rafael, Senhwa, Xrad.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adjuvance, Awakn, Cartesian, Eom, Meiji, Nouscom, Novartis, Oramed, Oncotelic, Regeneron, Reistone, Sorrento, Theravance, Timber.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bavarian Nordic, Foghorn, Hepagene, Kezar, Lexicon, Orphazyme Plus, Puretech, Sen-Jam.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Fate.